DA Davidson cut their price target on Medifast from $106.00 to $94.00 and set a “neutral” rating for the company in a report on Wednesday, February 22nd.

Source: https://www.etfdailynews.com/2023/04/15/exchange-traded-concepts-llc-purchases-3429-shares-of-medifast-inc-nysemed/

LSV Asset Management increased its stake in Medifast by 212.5% in the third quarter.

Source: https://www.americanbankingnews.com/2023/04/16/7044-shares-in-medifast-inc-nysemed-bought-by-legato-capital-management-llc.html

Medifast also currently offers an attractive dividend of $6.60.

Source: https://seekingalpha.com/article/4593723-medifast-attractively-valued-even-amidst-declining-fundamentals?source=feed_all_articles

Medifast, Inc, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific.

Source: https://www.etfdailynews.com/2023/01/08/versor-investments-lp-boosts-position-in-medifast-inc-nysemed/

Point72 Middle East FZE bought a new stake in Medifast during the fourth quarter worth about $57,000.

Source: https://www.americanbankingnews.com/2023/05/06/medifast-nysemed-downgraded-by-stocknews-com-to-hold.html

TD Asset Management Inc purchased a new stake in shares of Medifast, Inc. () during the 4th quarter, according to its most recent disclosure with the SEC.

Source: https://www.etfdailynews.com/2023/05/12/3800-shares-in-medifast-inc-nysemed-purchased-by-td-asset-management-inc/